PDS in the News
Recognizing the high stakes in the safety of next-generation immuno-oncology medicines, six major biopharma companies active in the space launched a project with the Project Data Sphere.
Open, collective innovation such as Project Data Sphere, designed to collate big data and bridge the distant segments of the health care industry, highlight the necessity of innovation in the sector.
The value of the active comparator arm data can be seen in a series of peer-accepted manuscripts that have been recently published based upon data aggregated within the Project Data Sphere Cancer Research Platform.
Project Data Sphere is taking advantage of new IT platforms and the rich target potential in discovery science to press for a larger industry consensus around new ways to release high-value data embedded in years of trials, all for the benefit of cancer patients.
A new scientific study, using crowdsourced data from multiple pharmaceutical companies, has helped reveal that a simple blood test can be used to tell almost immediately if a treatment is fighting off the disease in prostate cancer patients. Dr. Howard Scher, an oncologist at Memorial Sloan Kettering, led the research that analyzed crowdsourced data from the Project Data Sphere (PDS) initiative.
